<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer - Interactions investigated in the context of cancer dataset MI:0875"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation MI:0959"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Only protein-protein interactions full coverage MI:0957"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "imex curation curation depth MI:0955"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Cancer Cell (1535-6108) journal MI:0885"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "7 last-imex-assigned"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "2010 publication year MI:0886"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Anti-RAR-alpha antibody used. antibodies MI:0671"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "jizhang@sibs.ac.cn contact-email MI:0634"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Wang K., Wang P., Shi J., Zhu X., He M., Jia X., Yang X., Qiu F., Jin W., Qian M., Fang H., Mi J., Yang X., Xiao H., Minden M., Du Y., Chen Z., Zhang J. author-list MI:0636"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "TrEMBL Q15156 (PML-RAR fusion protein)has been used as a reference entry only, as the exact sequence of the fusion protein is not known. comment MI:0612"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "Re-chIp assay using ZnSO4-treated PR9 cells. exp-modification MI:0627"^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#comment> "PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia."^^<http://www.w3.org/2001/XMLSchema#string> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IM-13602> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-2609878> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#PXR-20159610> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#xref> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-102578> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_5811872405064717358> .
<HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_8513138041767195205> <http://www.biopax.org/release/biopax-level3.owl#experimentalForm> <HTTP://PATHWAYCOMMONS.ORG/PSI2BP#_3506680204208502563> .